Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05749289
PHASE2/PHASE3
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
View on ClinicalTrials.gov
Summary
This is an open-label whole-body PET/CT study for investigating the value of Al18F-octreotide PET/CT in patients with SSTR positive tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2022-12-20
Completion Date
2029-12-20
Last Updated
2026-04-06
Healthy Volunteers
No
Conditions
Interventions
DRUG
Al18F-octreotide
Al18F-octreotide I was injected into the patients before the PET/CT scans
Locations (1)
National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Chao Yang, China